<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Arq Bras Cir Dig</journal-id>
      <journal-id journal-id-type="iso-abbrev">Arq Bras Cir Dig</journal-id>
      <journal-id journal-id-type="publisher-id">abcd</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cirurgia Digestiva : ABCD</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0102-6720</issn>
      <issn pub-type="epub">2317-6326</issn>
      <publisher>
        <publisher-name>Col&#xE9;gio Brasileiro de Cirurgia Digestiva</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26537284</article-id>
      <article-id pub-id-type="pmc">4795317</article-id>
      <article-id pub-id-type="doi">10.1590/S0102-6720201500S100024</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter To The Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>CUSHING'S SYNDROME CAUSED BY AN ADRENOCORTICAL CARCINOMA AFTER A
BARIATRIC SURGERY: CASE REPORT</article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>S&#xED;ndrome de cushing causada por carcinoma adrenocortical ap&#xF3;s cirurgia
bari&#xE1;trica: relato de caso</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>SOUTO</surname>
            <given-names>K&#xE1;tia Elisabete Pires</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>PEREIRA</surname>
            <given-names>Daniela Aline</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>RAMOS</surname>
            <given-names>Mauricio Jacques</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>MOLINARI</surname>
            <given-names>Alberto Salgueiro</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>DAMIN</surname>
            <given-names>Daniel de Carvalho</given-names>
          </name>
          <xref ref-type="aff" rid="aff03">
<sup>2</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label>Endocrinology</aff>
      <aff id="aff02"><label>2</label>Digestive Surgery Services, Nossa Senhora da Concei&#xE7;&#xE3;o Hospital</aff>
      <aff id="aff03">&#xB3;Surgery Postgraduate Program, Hospital de Clinicas, Federal University of
Rio Grande do Sul, Porto Alegre, RS, Brazil</aff>
      <pub-date pub-type="epub-ppub">
        <month>12</month>
        <year>2015</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <month>12</month>
        <year>2015</year>
      </pub-date>
      <volume>28</volume>
      <issue>Suppl 1</issue>
      <fpage>87</fpage>
      <lpage>89</lpage>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0">
          <license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution License</license-p>
        </license>
      </permissions>
      <counts>
        <fig-count count="6"/>
        <table-count count="2"/>
        <equation-count count="0"/>
        <ref-count count="12"/>
        <page-count count="3"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Interest in the study of adrenocortical carcinoma has greatly increased in the last 12
years. In the last decade, more medical articles about this subject have been published
than in the last 50 years<xref rid="B01" ref-type="bibr">1</xref>. Adrenal carcinoma is
a rare and aggressive neoplasia and the affected patients have less than a 50% chance of
survival in five years. In the metastatic disease, the survival rate is less than
15%<xref rid="B02" ref-type="bibr">2</xref>. It has an incidence of 0.7 to 0.2 per 1
million people each year with bimodal distribution and it is predominant in females<xref rid="B02" ref-type="bibr">2</xref>. The incidence is shown to be higher in children
from the South of Brazil due to environmental and genetic factors<xref rid="B03" ref-type="bibr">3</xref>
<sup>,</sup>
<xref rid="B04" ref-type="bibr">4</xref>. It represents 3-6% of all carcinomas<xref rid="B03" ref-type="bibr">3</xref>. </p>
      <p>The purpose of this report is to relate a patient with morbid obesity that underwent
bariatric surgery and after that developed the Cushing's syndrome caused by an
adrenocortical carcinoma.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 54 years old patient was admitted to the endocrinology unit in February 2012. She had
a 3-month history of acne, hirsutism, muscle weakness in her lower limbs, increasing
levels of hypertension and diabetes mellitus imbalance. The physical exam revealed a
rounded face, clavicular fatness, a fatty hump, BP= 200X100 mmHg, BMI=32.4 kg/m&#xB2;. She
had a gastric bypass due to morbid obesity in 2009, with BMI=52,47 kg/m&#xB2;. Hormonal data
were consistent with CS- ACTH independent (<xref ref-type="table" rid="t1">Table
1</xref>).</p>
      <p>
<table-wrap id="t1" orientation="portrait" position="float"><label>TABLE 1</label><caption><title>- Laboratorial and weight evolution during the patient's follow-up</title></caption><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">
<bold>February 2012</bold>
</th><th align="left" rowspan="1" colspan="1">
<bold>May 2012</bold>
</th><th align="left" rowspan="1" colspan="1">
<bold>August 2012</bold>
</th><th align="left" rowspan="1" colspan="1">
<bold>March 2013</bold>
</th><th align="left" rowspan="1" colspan="1">
<bold>References</bold>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">ACTH</td><td align="left" rowspan="1" colspan="1">
<bold>&lt;</bold> 5.0</td><td align="left" rowspan="1" colspan="1">33.2</td><td align="left" rowspan="1" colspan="1">
<bold>&lt;</bold> 5.0</td><td align="left" rowspan="1" colspan="1">
<bold>&lt;</bold> 5.0</td><td align="left" rowspan="1" colspan="1">&lt;46 pg/ml</td></tr><tr><td align="left" rowspan="1" colspan="1">DHEA-S</td><td align="left" rowspan="1" colspan="1">1410</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">248.6</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">19-205 u/dl</td></tr><tr><td align="left" rowspan="1" colspan="1">Androstenedione</td><td align="left" rowspan="1" colspan="1">&gt;10</td><td align="left" rowspan="1" colspan="1">0.32</td><td align="left" rowspan="1" colspan="1">4.61</td><td align="left" rowspan="1" colspan="1">&gt;10</td><td align="left" rowspan="1" colspan="1">0.40-3.0 ng/ml</td></tr><tr><td align="left" rowspan="1" colspan="1">17 -alpha-OH-progesterone</td><td align="left" rowspan="1" colspan="1">2.14</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.23</td><td align="left" rowspan="1" colspan="1">297ng/dl **</td><td align="left" rowspan="1" colspan="1">0.19 -1.0 ng/ml</td></tr><tr><td align="left" rowspan="1" colspan="1">SHBG</td><td align="left" rowspan="1" colspan="1">45.60</td><td align="left" rowspan="1" colspan="1">128.2</td><td align="left" rowspan="1" colspan="1">56.20</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">18-114 nmol/l</td></tr><tr><td align="left" rowspan="1" colspan="1">Free testosterone</td><td align="left" rowspan="1" colspan="1">6.78</td><td align="left" rowspan="1" colspan="1">0.05</td><td align="left" rowspan="1" colspan="1">0.48</td><td align="left" rowspan="1" colspan="1">23.75</td><td align="left" rowspan="1" colspan="1">0.19 - 2.06 ng/dl</td></tr><tr><td align="left" rowspan="1" colspan="1">Total testosterone</td><td align="left" rowspan="1" colspan="1">6.55</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.53</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.06-0.82 ng/ml</td></tr><tr><td align="left" rowspan="1" colspan="1">Urinary free cortisol</td><td align="left" rowspan="1" colspan="1">224.1</td><td align="left" rowspan="1" colspan="1">18.8</td><td align="left" rowspan="1" colspan="1">90.9</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">10-90 ug/24 h</td></tr><tr><td align="left" rowspan="1" colspan="1">LDDST* cortisol</td><td align="left" rowspan="1" colspan="1">31.87</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">9.75</td><td align="left" rowspan="1" colspan="1">15.23</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">LH</td><td align="left" rowspan="1" colspan="1">&lt;0.1</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">19.2</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1.7 - 8.6mUl/ml</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p> DHEA-S=plasma dehydroepiandrosterone sulfate; *LDDST=low dose dexamethasone
suppression test; **change in the ng/dl method (VR: 59-344 ng/dl)</p></fn></table-wrap-foot></table-wrap>
</p>
      <p>Abdominal computed tomography showed an expanding lesion in the left adrenal area of
13.0X9.0 cm, with irregular contour lines and heterogeneous caption of contrast (<xref ref-type="fig" rid="f1">Figure 1</xref>).</p>
      <p>She was submitted to a left adrenalectomy and partial nephrectomy in April 2012. Her
anatomopathological exam result was 630 g, size 21X10X 5.0 cm (<xref ref-type="fig" rid="f2">Figure 2</xref>).</p>
      <p>The pathologic findings were: 15 mitosis in 50 high power fields and the nuclear
pleomorphisms was present; it showed the presence of confluent necrosis and capsular
invasion; Ki-67 index was 20% positive according to the immunohistochemical criteria
<bold>;</bold> TNM tumor stage was 3-0-0. </p>
      <p>There was regression of clinical and laboratorial alterations related to the Cushing's
syndrome. She had a follow-up as an outpatient and used mitotane 2 g per day. After
seven months, abdominal and thoracic tomography showed recurrence of the tumor and
metastasis in the lungs (<xref ref-type="fig" rid="f3">Figure 3</xref>).</p>
      <p>
<fig id="f1" orientation="portrait" position="float"><label>FIGURE 1</label><caption><title>- Abdominal tomography showing adrenal tumor</title></caption><graphic xlink:href="0102-6720-abcd-28-s1-00087-gf01"/></fig>
</p>
      <p>
<fig id="f2" orientation="portrait" position="float"><label>FIGURE 2</label><caption><title>- Resected adrenal tumor</title></caption><graphic xlink:href="0102-6720-abcd-28-s1-00087-gf02"/></fig>
</p>
      <p>
<fig id="f3" orientation="portrait" position="float"><label>FIGURE 3</label><caption><title> - Adrenal mass</title></caption><graphic xlink:href="0102-6720-abcd-28-s1-00087-gf03"/></fig>
</p>
      <p>As there was no satisfactory response from mitotane, cisplatin and etoposide, her
clinical situation worsened and she died 13 months after having had an adrenalectomy.
The patient's daughter has agreed in writing to allow the publication of this study.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Brazil is the country with the second highest numbers of bariatric surgeries and it has
the highest number of bariatric surgeons in the world<xref rid="B05" ref-type="bibr">5</xref>. Although Cushing syndrome is a rare cause of obesity, it is supposed that
some of the patients that have had bariatric surgery have it. There are few studies
about it in patients with morbid obesity<xref rid="B02" ref-type="bibr">2</xref>.
Cushing is a disease difficult to diagnose and many times its diagnosis happens too
late<xref rid="B06" ref-type="bibr">6</xref>. When hypercortisolism appears, it can
be an ACTH - dependent Cushing's syndrome (70 to 80%) or ACTH - independent caused by
adrenocortical tumors or hyperplasia adrenal<xref rid="B07" ref-type="bibr">7</xref>
<sup>,</sup>
<xref rid="B08" ref-type="bibr">8</xref>. It is more prevalent in high risk populations
such as obese people with poorly controlled diabetes and its incidence ranges between
3.3 to 5.8% in published studies <xref rid="B08" ref-type="bibr">8</xref>. Screening for
Cushing before bariatric surgery has been suggested in order to avoid a procedure that
could be lethal and irreversible as it has already been described<xref rid="B08" ref-type="bibr">8</xref>
<sup>,</sup>
<xref rid="B09" ref-type="bibr">9</xref>. There are reports about it over 9.33% in obese
patients<xref rid="B10" ref-type="bibr">10</xref>. Approximately 60% of adrenal
carcinomas are functioning and 70% are manifested by Cushing syndrome, associated or not
to virilization. Virilization and DHEA-S high levels are more associated to malign
tumors<xref rid="B11" ref-type="bibr">11</xref>. In those tumors, the symptoms
associated to the glucocorticoids excess develop fast (from 3 to 6 months)<xref rid="B02" ref-type="bibr">2</xref>. Patients with higher recurrence risk present a
high rate of malignity in the histology (Ki67 staining of &gt;10% of tumor cells, &gt;20
mitotic figures per 50 high power fields) no matter what the tumor size and the vascular
and capsular invasion<xref rid="B12" ref-type="bibr">12</xref>. Ki67 is the most
powerful detector of the located or advanced disease and it can guide the treatment<xref rid="B01" ref-type="bibr">1</xref>. Adrenal carcinomas grow very fast and very often
they present metastasis in the lungs and liver<xref rid="B11" ref-type="bibr">11</xref>.
This patient's adrenalectomy did not show evidence of metastasis. However, after seven
months she had a recurrence of the disease and there was lung metastasis. This case
highlights the fact that patients with morbid obesity should be investigated in regard
to other endocrinal diseases. Future studies are needed to evaluate the true Cushing
syndrome prevalence in this population<xref rid="B10" ref-type="bibr">10</xref>. It is
believed that this is the first case reported in the literature that refers functioning
adrenocortical carcinoma which was diagnosed after bariatric surgery. The authors
emphasize the importance of having an endocrinologist in the surgical team, who also
diagnoses and treats Cushing syndrome in morbidly obese patients.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="B01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fassnacht</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kroiss</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Allolio</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Update in adrenocortical carcinoma</article-title>
          <source>The Journal of clinical endocrinology and metabolism.</source>
          <year>2013</year>
          <volume>98</volume>
          <issue>12</issue>
          <fpage>4551</fpage>
          <lpage>4564</lpage>
          <pub-id pub-id-type="pmid">24081734</pub-id>
        </element-citation>
      </ref>
      <ref id="B02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fassnacht</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Terzolo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Allolio</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Baudin</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Haak</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Berruti</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Combination chemotherapy in advanced adrenocortical
carcinoma</article-title>
          <source>The New England journal of medicine.</source>
          <year>2012</year>
          <volume>366</volume>
          <issue>23</issue>
          <fpage>2189</fpage>
          <lpage>2197</lpage>
          <pub-id pub-id-type="pmid">22551107</pub-id>
        </element-citation>
      </ref>
      <ref id="B03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ribeiro</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Michalkiewicz</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Figueiredo</surname>
              <given-names>BC</given-names>
            </name>
            <name>
              <surname>DeLacerda</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Sandrini</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Pianovsky</surname>
              <given-names>MD</given-names>
            </name>
          </person-group>
          <article-title>Adrenocortical tumors in children</article-title>
          <source>Brazilian journal of medical and biological research = Revista brasileira de
pesquisas medicas e biologicas / Sociedade Brasileira de Biofisica [et
al].</source>
          <year>2000</year>
          <volume>33</volume>
          <issue>10</issue>
          <fpage>1225</fpage>
          <lpage>1234</lpage>
        </element-citation>
      </ref>
      <ref id="B04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sandrini</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>DeLacerda</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Childhood adrenocortical tumors</article-title>
          <source>The Journal of clinical endocrinology and metabolism.</source>
          <year>1997</year>
          <volume>82</volume>
          <issue>7</issue>
          <fpage>2027</fpage>
          <lpage>2031</lpage>
          <pub-id pub-id-type="pmid">9215267</pub-id>
        </element-citation>
      </ref>
      <ref id="B05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Buchwald</surname>
              <given-names>HO</given-names>
            </name>
          </person-group>
          <article-title>M</article-title>
          <source>Metabolic/Bariatric Surgery Worldwide 2011. Obesity surgery.</source>
          <year>2013</year>
          <volume>23</volume>
          <fpage>427</fpage>
          <lpage>436</lpage>
          <pub-id pub-id-type="pmid">23338049</pub-id>
        </element-citation>
      </ref>
      <ref id="B06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aron</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Cushing's Syndrome: why is diagnosis so difficult?</article-title>
          <source>Rev Endocr Metab Disord.</source>
          <year>2010</year>
          <fpage>105</fpage>
          <lpage>116</lpage>
          <pub-id pub-id-type="pmid">20217244</pub-id>
        </element-citation>
      </ref>
      <ref id="B07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stiles</surname>
              <given-names>LE</given-names>
            </name>
          </person-group>
          <article-title>Cushing syndrome and bariatric surgery: why, when, and how to evaluate
preoperatively</article-title>
          <source>Surgery for obesity and related diseases : official journal of the American
Society for Bariatric Surgery.</source>
          <year>2009</year>
          <volume>5</volume>
          <issue>1</issue>
          <fpage>119</fpage>
          <lpage>121</lpage>
          <pub-id pub-id-type="pmid">19161939</pub-id>
        </element-citation>
      </ref>
      <ref id="B08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fleseriu</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ludlam</surname>
              <given-names>WH</given-names>
            </name>
            <name>
              <surname>Teh</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Yedinak</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Deveney</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sheppard</surname>
              <given-names>BC</given-names>
            </name>
          </person-group>
          <article-title>Cushing's syndrome might be underappreciated in patients seeking
bariatric surgery: a plea for screening</article-title>
          <source>Surgery for obesity and related diseases : official journal of the American
Society for Bariatric Surgery.</source>
          <year>2009</year>
          <volume>5</volume>
          <issue>1</issue>
          <fpage>116</fpage>
          <lpage>119</lpage>
          <pub-id pub-id-type="pmid">18996772</pub-id>
        </element-citation>
      </ref>
      <ref id="B09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Savastano</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pivonello</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Colao</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Bariatric surgery for obesity and hidden Cushing
syndrome</article-title>
          <source>Surgery for obesity and related diseases : official journal of the American
Society for Bariatric Surgery.</source>
          <year>2009</year>
          <volume>5</volume>
          <issue>1</issue>
          <fpage>121</fpage>
          <lpage>122</lpage>
          <pub-id pub-id-type="pmid">19071067</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tiryakioglu</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Ugurlu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yalin</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yirmibescik</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Caglar</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Yetkin</surname>
              <given-names>DO</given-names>
            </name>
          </person-group>
          <article-title>Screening for Cushing's syndrome in obese patients</article-title>
          <source>Clinics.</source>
          <year>2010</year>
          <volume>65</volume>
          <issue>1</issue>
          <fpage>9</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="pmid">20126340</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nag</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>McCulloch</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Cushing's syndrome due to an adrenocortical carcinoma</article-title>
          <source>Postgraduate medical journal.</source>
          <year>2003</year>
          <volume>79</volume>
          <issue>934</issue>
          <fpage>466</fpage>
          <lpage>466</lpage>
          <pub-id pub-id-type="pmid">12954960</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berruti</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fassnacht</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Haak</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Else</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Baudin</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Sperone</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Prognostic Role of Overt Hypercortisolism in Completely Operated
Patients with Adrenocortical Cancer</article-title>
          <source>European urology.</source>
          <year>2013</year>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
